Operating Cash Flow (Statement)

$104.34M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$104.34Mperiod endingJun 30, 2026

BCRX Quarterly Cash from Operations (-$1.70M → $104.34M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

BCRX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-2,464,000
Mar 31, 2001	-2,231,000
Dec 31, 2000	-1,779,640
Sep 30, 2000	-2,140,000
Jun 30, 2000	-1,584,823
Mar 31, 2000	2,326,823
Dec 31, 1999	-300,000
Sep 30, 1999	-2,100,000
Jun 30, 1999	100,000
Mar 31, 1999	-2,600,000
Dec 31, 1998	4,100,000
Sep 30, 1998	-2,800,000
Jun 30, 1998	-2,900,000
Mar 31, 1998	-2,600,000
Dec 31, 1997	-3,000,000
Sep 30, 1997	-2,500,000
Jun 30, 1997	-1,600,000
Mar 31, 1997	-3,200,000
Dec 31, 1996	-1,600,000
Sep 30, 1996	-2,300,000
Jun 30, 1996	-900,000
Mar 31, 1996	-2,000,000
Dec 31, 1995	-1,600,000
Sep 30, 1995	-1,800,000
Jun 30, 1995	-1,200,000
Mar 31, 1995	-3,100,000
Dec 31, 1994	-1,500,000
Sep 30, 1994	-1,900,000
Jun 30, 1994	-1,400,000
Mar 31, 1994	-1,700,000